MedPath
HSA Approval

NIRABEN CAPSULE 200 mg

SIN10966P

NIRABEN CAPSULE 200 mg

NIRABEN CAPSULE 200 mg

June 3, 1999

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

A07AX03

nifuroxazide

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Aprogen Pharmaceuticals, Inc.

Active Ingredients

NIFUROXAZIDE

200 mg

Nifuroxazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NIRABEN CAPSULE 200 mg - HSA Approval | MedPath